{"id":11531,"date":"2023-05-14T13:38:46","date_gmt":"2023-05-14T12:38:46","guid":{"rendered":"https:\/\/biggeesblog.cymru\/?p=11531"},"modified":"2023-05-18T23:27:46","modified_gmt":"2023-05-18T22:27:46","slug":"when-a-former-pfizer-vice-president-tells-it-as-it-is-you-should-listen","status":"publish","type":"post","link":"https:\/\/biggeesblog.cymru\/index.php\/2023\/05\/14\/when-a-former-pfizer-vice-president-tells-it-as-it-is-you-should-listen\/","title":{"rendered":"When A Former Pfizer Vice President Tells It As It Is – YOU SHOULD LISTEN!"},"content":{"rendered":"

NOT Your Run Of The Mill “Conspiracy Theorist”<\/strong><\/h1>\n
\"\"

Dr. Michael Yeadon is an Allergy & Respiratory Therapeutic Area expert with 23 years in the pharmaceutical industry and was VP and Chief Scientific Officer (Allergy & Respiratory Research) with Pfizer., Inc. He trained as a biochemist and pharmacologist, obtaining his PhD from the University of Surrey (UK) in 1988. Dr. Yeadon has published over 40 original research articles.<\/p><\/div>\n

Check Out His Credentials:<\/strong><\/h2>\n

Dr. Michael Yeadon is an\u00a0Allergy & Respiratory Therapeutic Area expert<\/strong>\u00a0in the pharmaceutical industry. He trained as a biochemist and pharmacologist, obtaining his PhD from the University of Surrey (UK) in 1988.<\/p>\n

Dr. Yeadon then worked at the\u00a0Wellcome Research Labs<\/strong>\u00a0with Salvador Moncada with a research focus on airway hyper-responsiveness and effects of pollutants including ozone and working in drug discovery of 5-LO, COX, PAF, NO and lung inflammation. With colleagues, he was the first to detect exhaled NO in animals and later to induce NOS in lung via allergic triggers.<\/p>\n

As Pfizer’s former Vice President and Chief Scientist for Allergy & Respiratory, he spent 32 years in the industry leading new medicines research and\u00a0retired<\/a>\u00a0from the pharmaceutical giant with \u201cthe most senior research position\u201d in his field.<\/p>\n

Joining\u00a0Pfizer<\/strong>\u00a0in 1995, he was responsible for the growth and portfolio delivery of the Allergy & Respiratory pipeline within the company. He was responsible for target selection and the progress into humans of new molecules, leading teams of up to 200 staff across all disciplines and won an Achievement Award for productivity in 2008.<\/p>\n

Under his leadership the research unit invented oral and inhaled NCEs which delivered multiple positive clinical proofs of concept in asthma, allergic rhinitis and COPD. He led productive collaborations such as with\u00a0Rigel Pharmaceuticals<\/strong>\u00a0(SYK inhibitors) and was involved in the licensing of\u00a0Spiriva<\/strong>\u00a0and acquisition of the\u00a0Meridica<\/strong>\u00a0(inhaler device) company.<\/p>\n

Dr. Yeadon has published over 40 original research articles and now consults and partners with a number of biotechnology companies. Before working with\u00a0Apellis<\/strong>, Dr. Yeadon was VP and Chief Scientific Officer (Allergy & Respiratory Research) with\u00a0Pfizer<\/strong>.<\/p>\n

At The Top Of His Game<\/strong><\/h2>\n

We are not repeating what we heard from the guy down the pub. This a former Pfizer Vice President (think about that for a minute). When he explains to you what he believes the\u00a0 eugenicists, at the elite globalist cabal’s agenda is for the world’s population, you should take what he says VERY<\/em><\/strong> seriously<\/strong>:<\/p>\n